June 1, 2026 Flerie’s portfolio company Xintela presents positive results from clinical study with its stem cell product XSTEM Read news release
May 29, 2026 11:00 Regulatory Change in the total number of shares and votes in Flerie AB (publ) Read news release
June 1, 2026 Flerie’s portfolio company Xintela presents positive results from clinical study with its stem cell product XSTEM Read news release
May 20, 2026 Flerie’s portfolio company Prokarium presents positive interim data from clinical study in bladder cancer Read news release
April 21, 2026 Flerie’s portfolio company Mendus advances clinical program with first patient enrolled in phase 1b trial Read news release